PRECISION OPTICS CORPORATION, INC. Cost of Revenue
PRECISION OPTICS CORPORATION, INC. (POCI) reported Cost of Revenue of $15.69 million for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2025-09-29
- PRECISION OPTICS CORPORATION, INC. cost of revenue for the quarter ending 2025-06-30 was $5.38M, a 45.79% increase year-over-year.
- PRECISION OPTICS CORPORATION, INC. cost of revenue for the quarter ending 2025-03-31 was $3.77M, a 11.35% increase year-over-year.
- PRECISION OPTICS CORPORATION, INC. cost of revenue for the quarter ending 2024-12-31 was $3.46M, a 2.48% increase year-over-year.
- PRECISION OPTICS CORPORATION, INC. cost of revenue for the quarter ending 2024-09-30 was $3.08M, a 7.77% increase year-over-year.
- PRECISION OPTICS CORPORATION, INC. cost of revenue for fiscal 2025 was $15.69M, a 17.89% increase from fiscal 2024.
- PRECISION OPTICS CORPORATION, INC. cost of revenue for fiscal 2024 was $13.31M, a 0.03% decline from fiscal 2023.
- PRECISION OPTICS CORPORATION, INC. cost of revenue for fiscal 2023 was $13.31M, a 23.82% increase from fiscal 2022.
- PRECISION OPTICS CORPORATION, INC. cost of revenue for fiscal 2022 was $10.75M, a 48.45% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|---|---|
| 2025-06-30 | $5.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $9.15M derived: sum of 2 quarters · filed 2025-09-29 | $12.61M derived: sum of 3 quarters · filed 2025-09-29 | $15.69M 10-K · filed 2025-09-29 | ||
| 2025-03-31 | $3.77M 10-Q · filed 2025-05-15 | $7.22M derived: sum of 2 quarters · filed 2025-05-15 | $10.30M 10-Q · filed 2025-05-15 | $14.00M derived: sum of 4 quarters · filed 2025-09-29 | ||
| 2024-12-31 | $3.46M 10-Q · filed 2025-02-13 | $6.54M 10-Q · filed 2025-02-13 | $10.23M derived: sum of 3 quarters · filed 2025-09-29 | $13.61M derived: sum of 4 quarters · filed 2025-09-29 | ||
| 2024-09-30 | $3.08M 10-Q · filed 2024-11-14 | $6.77M derived: sum of 2 quarters · filed 2025-09-29 | $10.16M derived: sum of 3 quarters · filed 2025-09-29 | $13.53M derived: sum of 4 quarters · filed 2025-09-29 | ||
| 2024-06-30 | $3.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $7.08M derived: sum of 2 quarters · filed 2025-09-29 | $10.45M derived: sum of 3 quarters · filed 2025-09-29 | $13.31M 10-K · filed 2025-09-29 | ||
| 2024-03-31 | $3.38M 10-Q · filed 2025-05-15 | $6.76M derived: sum of 2 quarters · filed 2025-05-15 | $9.61M 10-Q · filed 2025-05-15 | $12.88M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $3.37M 10-Q · filed 2025-02-13 | $6.23M 10-Q · filed 2025-02-13 | $9.50M derived: sum of 3 quarters · filed 2025-02-13 | $12.81M derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-09-30 | $2.86M 10-Q · filed 2024-11-14 | $6.12M derived: sum of 2 quarters · filed 2024-11-14 | $9.43M derived: sum of 3 quarters · filed 2024-11-14 | $12.72M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $6.58M derived: sum of 2 quarters · filed 2024-09-30 | $9.86M derived: sum of 3 quarters · filed 2024-09-30 | $13.31M 10-K · filed 2024-09-30 | ||
| 2023-03-31 | $3.31M 10-Q · filed 2024-05-15 | $6.60M derived: sum of 2 quarters · filed 2024-05-15 | $10.05M 10-Q · filed 2024-05-15 | $13.40M derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $3.29M 10-Q · filed 2024-02-14 | $3.16M 10-Q · filed 2023-02-14 | $6.73M 10-Q · filed 2024-02-14 | $6.52M 10-Q · filed 2023-02-14 | $10.09M derived: sum of 3 quarters · filed 2024-02-14 | $13.01M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-09-30 | $3.45M 10-Q · filed 2023-11-14 | $3.36M 10-Q · filed 2022-11-14 | $6.80M derived: sum of 2 quarters · filed 2023-11-14 | $9.72M derived: sum of 3 quarters · filed 2023-11-14 | $12.50M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $3.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $6.28M derived: sum of 2 quarters · filed 2023-09-28 | $9.05M derived: sum of 3 quarters · filed 2023-09-28 | $10.75M 10-K · filed 2023-09-28 | ||
| 2022-03-31 | $2.92M 10-Q · filed 2023-05-15 | $5.70M derived: sum of 2 quarters · filed 2023-05-15 | $7.40M 10-Q · filed 2023-05-15 | $9.29M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $2.78M 10-Q · filed 2023-02-14 | $4.47M 10-Q · filed 2023-02-14 | $6.36M derived: sum of 3 quarters · filed 2023-02-14 | $8.00M derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-09-30 | $1.70M 10-Q · filed 2022-11-14 | $3.58M derived: sum of 2 quarters · filed 2022-11-14 | $5.22M derived: sum of 3 quarters · filed 2022-11-14 | $7.16M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $3.53M derived: sum of 2 quarters · filed 2022-09-27 | $5.46M derived: sum of 3 quarters · filed 2022-09-27 | $7.24M 10-K · filed 2022-09-27 | ||
| 2021-03-31 | $1.64M 10-Q · filed 2022-05-16 | $3.57M derived: sum of 2 quarters · filed 2022-05-16 | $5.35M 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $1.93M 10-Q · filed 2022-02-14 | $3.71M 10-Q · filed 2022-02-14 | ||||
| 2020-09-30 | $1.78M 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | $6.56M 10-K · filed 2021-09-28 | |||||
| 2019-12-31 | $1.88M 10-Q · filed 2020-02-13 | $3.42M 10-Q · filed 2020-02-13 | $4.95M derived: sum of 3 quarters · filed 2020-09-24 | $5.88M derived: sum of 4 quarters · filed 2020-09-24 | ||
| 2019-09-30 | $1.54M 10-Q · filed 2019-11-14 | $3.07M derived: sum of 2 quarters · filed 2020-09-24 | $4.00M derived: sum of 3 quarters · filed 2020-09-24 | $5.13M derived: sum of 4 quarters · filed 2020-09-24 | ||
| 2019-06-30 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-24 | $2.46M derived: sum of 2 quarters · filed 2020-09-24 | $3.58M derived: sum of 3 quarters · filed 2020-09-24 | $4.68M 10-K · filed 2020-09-24 | ||
| 2019-03-31 | $930.52K 10-Q · filed 2019-05-15 | $2.05M derived: sum of 2 quarters · filed 2020-02-13 | $3.15M 10-Q · filed 2019-05-15 | $4.05M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-12-31 | $1.12M 10-Q · filed 2020-02-13 | $2.22M 10-Q · filed 2020-02-13 | $3.12M derived: sum of 3 quarters · filed 2020-02-13 | $3.62M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-09-30 | $1.10M 10-Q · filed 2019-11-14 | $2.00M derived: sum of 2 quarters · filed 2019-11-14 | $2.50M derived: sum of 3 quarters · filed 2019-11-14 | $3.01M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | $902.13K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | $1.40M derived: sum of 2 quarters · filed 2019-09-26 | $1.91M derived: sum of 3 quarters · filed 2019-09-26 | $2.56M 10-K · filed 2019-09-26 | ||
| 2018-03-31 | $499.44K 10-Q · filed 2019-05-15 | $1.01M derived: sum of 2 quarters · filed 2019-05-15 | $1.65M 10-Q · filed 2019-05-15 | $2.19M derived: sum of 4 quarters · filed 2019-05-15 | ||
| 2017-12-31 | $512.55K 10-Q · filed 2019-02-12 | $1.15M 10-Q · filed 2019-02-12 | $1.69M derived: sum of 3 quarters · filed 2019-02-12 | $2.40M derived: sum of 4 quarters · filed 2019-02-12 | ||
| 2017-09-30 | $642.00K 10-Q · filed 2018-11-14 | $1.18M derived: sum of 2 quarters · filed 2018-11-14 | $1.89M derived: sum of 3 quarters · filed 2018-11-14 | |||
| 2017-06-30 | $540.08K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-27 | $1.25M derived: sum of 2 quarters · filed 2018-09-27 | $2.38M 10-K · filed 2018-09-27 | |||
| 2017-03-31 | $705.06K 10-Q · filed 2018-05-15 | $1.84M 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |